Commission Implementing Regulation (EU) 2019/168 of 31 January 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) Strain QST 713, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. israeliensis, Bacillus thuringiensis subsp. kurstaki, Beauveria bassiana, benfluralin, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, epoxiconazole, fenpyroximate, fluazinam, flutolanil, fosetyl, Lecanicillium muscarium, mepanipyrim, mepiquat, Metarhizium anisopliae var. Anisopliae, metconazole, metrafenone, Phlebiopsis gigantea, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, Pythium oligandrum, rimsulfuron, spinosad, Streptomyces K61, thiacloprid, tolclofos-methyl, Trichoderma asperellum, Trichoderma atroviride, Trichoderma gamsii, Trichoderma harzianum, triclopyr, trinexapac, triticonazole, Verticillium albo-atrum and ziram (Text with EEA relevance.)
Date: 2019-01-31
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: market approval, plant health control, plant health product








L_2019033EN.01000101.xml










5.2.2019   


EN


Official Journal of the European Union


L 33/1








            COMMISSION IMPLEMENTING REGULATION (EU) 2019/168
of 31 January 2019
         
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) Strain QST 713, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. israeliensis, Bacillus thuringiensis subsp. kurstaki, Beauveria bassiana, benfluralin, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, epoxiconazole, fenpyroximate, fluazinam, flutolanil, fosetyl, Lecanicillium muscarium, mepanipyrim, mepiquat, Metarhizium anisopliae var. Anisopliae, metconazole, metrafenone, Phlebiopsis gigantea, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, Pythium oligandrum, rimsulfuron, spinosad, Streptomyces K61, thiacloprid, tolclofos-methyl, Trichoderma asperellum, Trichoderma atroviride, Trichoderma gamsii, Trichoderma harzianum, triclopyr, trinexapac, triticonazole, Verticillium albo-atrum and ziram
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,

Whereas:







(1)


Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.












(2)


The approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, clodinafop, clopyralid, cyprodinil, dichlorprop-P, fosetyl, mepanipyrim, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, rimsulfuron, spinosad, thiacloprid, tolclofos-methyl, triclopyr, trinexapac, triticonazole and ziram were last extended by Commission Implementing Regulation (EU) 2018/524 (3). The approval periods of those substances will expire on 30 April 2019.












(3)


The approval periods of the active substances benfluralin, fluazinam, flutolanil and mepiquat will expire on 28 February 2019.












(4)


The approval periods of the active substances abamectin, Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. israeliensis, Bacillus thuringiensis subsp. kurstaki, Beauveria bassiana, Cydia pomonella Granulovirus (CpGV), epoxiconazole, fenpyroximate, Lecanicillium muscarium, Metarhizium anisopliae var. Anisopliae, Phlebiopsis gigantea, Pythium oligandrum, Streptomyces K61, Trichoderma asperellum, Trichoderma atroviride, Trichoderma gamsii, Trichoderma harzianum and Verticillium albo-atrum will expire on 30 April 2019.












(5)


Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (4).












(6)


Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approval of those active substances are likely to expire before a decision on the renewal of the approval has been taken. It is therefore necessary to postpone the expiry of the approval periods.












(7)


In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.












(8)


Taking into account that the approval periods of the active substances benfluralin, fluazinam, flutolanil and mepiquat expire on 28 February 2019, this Regulation should enter into force as soon as possible.












(9)


Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.












(10)


The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,





HAS ADOPTED THIS REGULATION:



Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.


Article 2
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 31 January 2019.


For the Commission


The President

Jean-Claude JUNCKER
            





(1)  
            OJ L 309, 24.11.2009, p. 1.

(2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

(3)  Commission Implementing Regulation (EU) 2018/524 of 28 March 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, clodinafop, clopyralid, cyprodinil, dichlorprop-P, fosetyl, mepanipyrim, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, quinoxyfen, rimsulfuron, spinosad, thiacloprid, thiamethoxam, thiram, tolclofos-methyl, triclopyr, trinexapac, triticonazole and ziram (OJ L 88, 4.4.2018, p. 4).

(4)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).




ANNEX
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:






(1)


in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘30 April 2020’;










(2)


in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis strain: MA 342, the date is replaced by ‘30 April 2020’;










(3)


in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by ‘30 April 2020’;










(4)


in the sixth column, expiration of approval, of row 92, Thiacloprid, the date is replaced by ‘30 April 2020’;










(5)


in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced by ‘30 April 2020’;










(6)


in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘30 April 2020’;










(7)


in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘30 April 2020’;










(8)


in the sixth column, expiration of approval, of row 126, Tolclofos-methyl, the date is replaced by ‘30 April 2020’;










(9)


in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘30 April 2020’;










(10)


in the sixth column, expiration of approval, of row 129, Clopyralid, the date is replaced by ‘30 April 2020’;










(11)


in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘30 April 2020’;










(12)


in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘30 April 2020’;










(13)


in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by ‘30 April 2020’;










(14)


in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘30 April 2020’;










(15)


in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by ‘30 April 2020’;










(16)


in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 April 2020’;










(17)


in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by ‘30 April 2020’;










(18)


in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by ‘30 April 2020’;










(19)


in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) strain QST 713, the date is replaced by ‘30 April 2020’;










(20)


in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘30 April 2020’;










(21)


in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘29 February 2020’;










(22)


in the sixth column, expiration of approval, of row 188, Benfluralin, the date is replaced by ‘29 February 2020’;










(23)


in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘29 February 2020’;










(24)


in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘29 February 2020’;










(25)


in the sixth column, expiration of approval, of row 193, Bacillus thuringiensis subsp. Aizawai, the date is replaced by ‘30 April 2020’;










(26)


in the sixth column, expiration of approval, of row 194, Bacillus thuringiensis subsp. israeliensis, the date is replaced by ‘30 April 2020’;










(27)


in the sixth column, expiration of approval, of row 195, Bacillus thuringiensis subsp. kurstaki, the date is replaced by ‘30 April 2020’;










(28)


in the sixth column, expiration of approval, of row 197, Beauveria bassiana, the date is replaced by ‘30 April 2020’;










(29)


in the sixth column, expiration of approval, of row 198, Cydia pomonella Granulovirus (CpGV), the date is replaced by ‘30 April 2020’;










(30)


in the sixth column, expiration of approval, of row 199, Lecanicillium muscarium, the date is replaced by ‘30 April 2020’;










(31)


in the sixth column, expiration of approval, of row 200, Metarhizium anisopliae var. Anisopliae, the date is replaced by ‘30 April 2020’;










(32)


in the sixth column, expiration of approval, of row 201, Phlebiopsis gigantea, the date is replaced by ‘30 April 2020’;










(33)


in the sixth column, expiration of approval, of row 202, Pythium oligandrum, the date is replaced by ‘30 April 2020’;










(34)


in the sixth column, expiration of approval, of row 203, Streptomyces K61, the date is replaced by ‘30 April 2020’;










(35)


in the sixth column, expiration of approval, of row 204, Trichoderma atroviride, the date is replaced by ‘30 April 2020’;










(36)


in the sixth column, expiration of approval, of row 206, Trichoderma harzianum, the date is replaced by ‘30 April 2020’;










(37)


in the sixth column, expiration of approval, of row 207, Trichoderma asperellum, the date is replaced by ‘30 April 2020’;










(38)


in the sixth column, expiration of approval, of row 208, Trichoderma gamsii, the date is replaced by ‘30 April 2020’;










(39)


in the sixth column, expiration of approval, of row 209, Verticillium albo-atrum, the date is replaced by ‘30 April 2020’;










(40)


in the sixth column, expiration of approval, of row 210, Abamectin, the date is replaced by ‘30 April 2020’;










(41)


in the sixth column, expiration of approval, of row 211, Epoxiconazole, the date is replaced by ‘30 April 2020’;










(42)


in the sixth column, expiration of approval, of row 213, Fenpyroximate, the date is replaced by ‘30 April 2020’.